GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $29,500,000 | -12.7% | 535,000 | 0.0% | 0.58% | -21.4% |
Q2 2020 | $33,775,000 | +23.6% | 535,000 | 0.0% | 0.73% | -17.1% |
Q1 2020 | $27,333,000 | -35.7% | 535,000 | 0.0% | 0.88% | -26.1% |
Q4 2019 | $42,527,000 | +63.8% | 535,000 | 0.0% | 1.20% | +39.6% |
Q3 2019 | $25,958,000 | -7.8% | 535,000 | 0.0% | 0.86% | +0.4% |
Q2 2019 | $28,141,000 | +44.9% | 535,000 | +45.8% | 0.86% | +28.0% |
Q1 2019 | $19,425,000 | +28.9% | 367,000 | 0.0% | 0.67% | +0.1% |
Q4 2018 | $15,065,000 | +72.4% | 367,000 | +59.6% | 0.67% | +107.8% |
Q3 2018 | $8,740,000 | +48.1% | 230,000 | +21.1% | 0.32% | -3.9% |
Q3 2017 | $5,900,000 | +13.5% | 190,000 | 0.0% | 0.33% | +3.1% |
Q2 2017 | $5,197,000 | -14.5% | 190,000 | +15.2% | 0.32% | -19.6% |
Q1 2017 | $6,080,000 | +155.0% | 165,000 | 0.0% | 0.40% | +160.0% |
Q4 2016 | $2,384,000 | -37.3% | 165,000 | 0.0% | 0.16% | -33.2% |
Q3 2016 | $3,803,000 | +38.9% | 165,000 | 0.0% | 0.23% | +38.9% |
Q2 2016 | $2,737,000 | +4.6% | 165,000 | 0.0% | 0.17% | +14.4% |
Q1 2016 | $2,617,000 | -50.9% | 165,000 | 0.0% | 0.15% | -45.3% |
Q4 2015 | $5,334,000 | +716.8% | 165,000 | +966.0% | 0.27% | +602.6% |
Q3 2015 | $653,000 | – | 15,479 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |